Orion Biologics
Scope
Date
~
-
Food & Beverage
Korea’s Orion to ship bottled water to China to challenge Evian
Orion Holdings Corp., the holding company of South Korea’s confectionary and snack maker Orion Corp., is set to export bottled water to China,...
Apr 12, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics signs ADC CDO deal with LegoChem Bio
Samsung Biologics Co. has agreed with South Korean biotech company LegoChem Biosciences Inc. to provide contract development organization (CDO) serv...
Feb 07, 2024 (Gmt+09:00)
-
Food & Beverage
Orion, VNUA to team up for potato production
South Korea’s confectionery and snack maker Orion Corp. announced on Friday that it signed a strategic partnership agreement with the Institut...
Jan 26, 2024 (Gmt+09:00)
-
Bio & Pharma
Lotte Biologics, NJ Bio to jointly develop ADC
South Korea's Lotte Biologics Co. announced on Monday that it has signed a strategic business agreement with NJ Bio, a US-based preclinical and clin...
Jan 22, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Orion to buy control of biotech startup LegoChem for $415 mn
South Korea’s snack and confectionery maker Orion Group has agreed to buy a controlling stake in LegoChem Biosciences Inc., a Korean biotech s...
Jan 15, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics reaches record-breaking annual orders
Samsung Biologics Co., the world’s top contract manufacturing organization (CMO) by capacity, surpassed the annual contract manufacturing orde...
Nov 28, 2023 (Gmt+09:00)
-
Bio & Pharma
Lotte builds US antibody-drug conjugate plant with $82 mn
South Korea’s Lotte Biologics Co. is establishing an antibody-drug conjugate (ADC) factory in Syracuse, New York, with an investment of 110 bi...
Oct 31, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics eyes new drugmaker acquisitions
BARCELONA -- Samsung Biologics Co., the world’s top contract manufacturing organization by capacity, is looking for acquisitions of new drugma...
Oct 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics partners with Europe's largest VC
Samsung Biologics Co., the world's largest contract drug manufacturer, announced on Tuesday it has teamed up with global biotech venture capitalist ...
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharma’s Phase 3 trials for anti-obesity medicine approved
South Korea’s Hanmi Pharmaceutical Co. on Monday said the Ministry of Food and Drug Safety approved Phase 3 clinical trials for the company&...
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Lotte Biologics to break ground on 1st local CDMO plant in 2024
South Korea’s Lotte Biologics Co. is set to start building its first local facility for drug manufacturing next year, aiming for 400,000 liter...
Oct 05, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Biologics partners with Indian company for CDMO
Prestige Biologics Co., a South Korean biopharmaceutical contract development and manufacturing organization (CDMO) company, is expanding its CDMO b...
Sep 22, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics wins $242 mn order from Bristol Myers Squibb
Samsung Biologics Co., the world’s largest contract drugmaker, said on Monday it has signed an agreement to produce $242 million worth of anti...
Sep 18, 2023 (Gmt+09:00)
-
Food & Beverage
Snack maker Orion earns dividends from Vietnam for 1st time
South Korea’s confectionery and snack manufacturer Orion Corp. collected dividends from its Vietnamese unit for the first time as the company ...
Sep 07, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Pharmteco gears up for big leap in advanced biotherapies
SK Pharmteco Co., South Korean conglomerate SK Group’s contract development and manufacturing organization (CDMO), is upping the ante in its b...
Aug 17, 2023 (Gmt+09:00)
-
Food & Beverage
Orion teams up with Dutch Mill to tap Vietnamese dairy market
South Korea's Orion Corp. announced on Tuesday its strategic collaboration with Thailand's dairy behemoth, Dutch Mill Co., marking its ambitious ent...
Aug 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Novomics expands presence in Chinese cancer market
South Korean molecular diagnostics company Novomics Co. announced on Wednesday that it has signed a collaboration agreement with Chinese molecular d...
Jul 19, 2023 (Gmt+09:00)
-
Bio & Pharma
Novartis $391 mn deal powers Samsung Biologics backlogs to record high
Samsung Biologics Co., the world’s top contract manufacturing organization by capacity, inked a $391 million contract from Novartis, nearly fi...
Jul 10, 2023 (Gmt+09:00)
-
Carbon neutrality
Samsung Biologics, Celltrion pledge major CO2 cuts
South Korea’s No. 1 biopharmaceutical company Samsung BioLogics Co. and No. 2 Celltrion Inc. produced higher CO2 emissions last year than in 2...
Jul 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics wins $897 mn in two deals with Pfizer
Samsung Biologics Co., the world’s largest contract manufacturing organization (CMO) in terms of production capacity, said on Tuesday it has w...
Jul 04, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics, Pfizer sign $411.3 mn agreement for long-term CDMO
Samsung Biologics Co., the world’s No. 1 contract drugmaker, announced a groundbreaking strategic partnership with Pfizer on Thursday, marking...
Jun 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics to double production by 2032; eyes ADCs, M&As
BOSTON – Samsung Biologics Co., the world’s No. 1 contract drugmaker, plans to more than double its total annual production capacity to ...
Jun 07, 2023 (Gmt+09:00)
-
Bio & Pharma
BIO USA 2023 to draw S.Korean biotech leaders, startups
More than 500 South Korean companies from top business groups to AI-based biotech startups are slated to attend the Bio International Convention 202...
May 30, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Bertis releases two academic findings at AOHUPO conference
Bertis, South Korean company specializing in the development of proteomics-based precision medicine technology, announced on Monday that it presente...
May 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung to nurture biotech as next growth engine after chips: Lee
Samsung Group leader Lee Jae-yong, currently in the US, has vowed to make biotechnology the conglomerate’s second core strategic business afte...
May 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Lotte Biologics invests in S.Korean bio-venture Pinotbio
South Korea’s Lotte Biologics Co. said on Friday that it has made an equity investment in Pinotbio, Inc. for the development of antibody-drug ...
Apr 21, 2023 (Gmt+09:00)
-
Bio & Pharma
Lotte Biologics to invest additional $48 mn in US plant
South Korea’s Lotte Biologics Co. held a plaque ceremony on Monday to commemorate the acquisition of a pharmaceutical production plant from Br...
Apr 18, 2023 (Gmt+09:00)
-
Food & Beverage
Orion’s Turtle Chips launches in Vietnam, India
South Korea's confectionary giant Orion Corp. is launching its popular snack "Kkobuk Chip" in Vietnam and India. Orion announced on Monday that it h...
Apr 17, 2023 (Gmt+09:00)
-
Korean food
S. Korea's Orion sees brisk sales growth in Vietnam, Russia
South Korea's confectionary giant Orion Corp. has seen brisk sales growth this year, pushing out rival CJ CheilJedang Corp. to solidify its dominanc...
Apr 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Lotte Biologics, Excellgene to collaborate on CDO biz
Lotte Biologics, South Korea's biopharmaceutical contract development and manufacturing organization (CDMO) company, announced on Sunday that it has...
Apr 03, 2023 (Gmt+09:00)